BioCentury
ARTICLE | Clinical News

Abelcet: Marketed

May 24, 1999 7:00 AM UTC

Researchers presented data showing a 17 percent mortality rate among 12 liver transplant patients with invasive aspergillosis treated with Abelcet compared to a historical control of 83 percent mortal...